These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1426098)

  • 1. In vivo cell cycle characteristics of pediatric leukemia patients.
    Masterson M; Lampkin B; Yousuf N; Sheikh Y; Raza A
    Exp Hematol; 1992 Nov; 20(10):1184-7. PubMed ID: 1426098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle kinetics in childhood acute leukemia studied with in vitro bromodeoxyuridine labeling, Ki67-reactivity, and flow cytometry.
    Tsurusawa M; Aoyama M; Saeki K; Fujimoto T
    Leukemia; 1995 Nov; 9(11):1921-5. PubMed ID: 7475284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of cell cycle in acute leukemias and non-Hodgkin's lymphomas in children].
    Pituch-Noworolska A; Gawlicka M
    Acta Haematol Pol; 1993; 24(4):365-71. PubMed ID: 8303983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
    Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H
    Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two double labeling techniques to measure cell cycle kinetics in myeloid leukemias.
    Yousuf N; Yanik GA; George BA; Masterson M; Mazewski CM; White LM; Miller MA; Lampkin BC; Raza A
    Anticancer Res; 1991; 11(3):1195-9. PubMed ID: 1888149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia.
    Raza A; Ucar K; Preisler HD
    Cytometry; 1985 Nov; 6(6):633-40. PubMed ID: 3905302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric determination with bromodeoxyuridine/DNA assay of sensitivity of S-phase cells to cytosine arabinoside in childhood acute lymphoblastic leukemia.
    Katano N; Tsurusawa M; Niwa M; Fujimoto T
    Am J Pediatr Hematol Oncol; 1989; 11(4):411-6. PubMed ID: 2618975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle characteristics in myeloid leukemias.
    Raza A; Khan SP; Mehdi I; Imren S; Yasin Z; Preisler HD
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():26-9. PubMed ID: 2713557
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemia.
    Spanaki A; Linardakis E; Perdikogianni C; Stiakaki E; Morotti A; Cilloni D; Kalmanti M
    Leuk Res; 2007 Apr; 31(4):570-2. PubMed ID: 16876863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
    Wang J; Wang T; Li S; Lin L; Gang Y
    Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine.
    Raza A; Alvi S; Broady-Robinson L; Showel M; Cartlidge J; Mundle SD; Shetty VT; Borok RZ; Dar SE; Chopra HK; Span L; Parcharidou A; Hines C; Gezer S; Venugopal P; Loew J; Showel J; Alston D; Hernandez B; Rifkin S; Robin E; Shah R; Gregory SA
    Exp Hematol; 1997 Jun; 25(6):530-5. PubMed ID: 9197332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative measurement of spontaneous apoptosis in pediatric acute leukemia by different techniques.
    Savitskiy VP; Shman TV; Potapnev MP
    Cytometry B Clin Cytom; 2003 Nov; 56(1):16-22. PubMed ID: 14582133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of nucleolar organizer regions in human leukemic cells.
    Grotto HZ; Metze K; Lorand-Metze I
    Anal Cell Pathol; 1993 Jul; 5(4):203-12. PubMed ID: 8363982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia.
    Markaki EA; Stiakaki E; Zafiropoulos A; Arvanitis DA; Katzilakis N; Dimitriou H; Spandidos DA; Kalmanti M
    Pediatr Blood Cancer; 2006 Jul; 47(1):14-21. PubMed ID: 16526056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of a proliferation associated-nuclear antigen defined by Ki-67 monoclonal antibody in childhood acute leukemia].
    Ito M; Tsurusawa M; Kawai S; Fujimoto T
    Rinsho Ketsueki; 1995 Aug; 36(8):713-9. PubMed ID: 7563603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
    Karp JE; Passaniti A; Gojo I; Kaufmann S; Bible K; Garimella TS; Greer J; Briel J; Smith BD; Gore SD; Tidwell ML; Ross DD; Wright JJ; Colevas AD; Bauer KS
    Clin Cancer Res; 2005 Dec; 11(23):8403-12. PubMed ID: 16322302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelonecrosis in acute leukemia.
    Prajapati NC; Singh T; Gautam P; Dubey AP; Choudhury P; Puri RK
    Indian Pediatr; 1994 Jan; 31(1):60-4. PubMed ID: 7883324
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
    Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytophotometry of granulocytes in chronic granulocytic leukemia patients. Part I. Cell cycle distribution, S-phase transition and quantitative cytochemistry.
    Kotelnikov VM; Lishmanova NG; Khoroshko ND; Dultsyna SM; Alieva TM; Khrust YuR ; Kozinets GI
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):585-95. PubMed ID: 2448196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
    Karp JE; Ross DD; Yang W; Tidwell ML; Wei Y; Greer J; Mann DL; Nakanishi T; Wright JJ; Colevas AD
    Clin Cancer Res; 2003 Jan; 9(1):307-15. PubMed ID: 12538483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.